Valganciclovir (American Health Packaging)


Welcome to the PulseAid listing for the Valganciclovir drug offered from American Health Packaging. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Health Packaging
NON-PROPRIETARY NAME: Valganciclovir
SUBSTANCE NAME: VALGANCICLOVIR HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-01-01
END MARKETING DATE: 0000-00-00


Valganciclovir HUMAN PRESCRIPTION DRUG Details:

Item DescriptionValganciclovir from American Health Packaging
LABELER NAME: American Health Packaging
DEA SCHEDULE:
ACTIVE STRENGTH: 450(mg/1)
START MARKETING DATE: 2015-01-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68084-965_592ba66c-ed47-013f-e053-2991aa0a39e2
PRODUCT NDC: 68084-965
APPLICATION NUMBER: ANDA203511

Other VALGANCICLOVIR HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Valganciclovir hydrochloride for Oral
American Health PackagingValganciclovir
Aurobindo Pharma LimitedVALGANCICLOVIR HYDROCHLORIDE
AvKARE, Inc.Valganciclovir
AvPAKValganciclovir
Camber Pharmaceuticals, Inc.Valganciclovir
Dr. Reddy’s Laboratories LimitedValganciclovir
Genentech, Inc.Valcyte
McKesson CorporationVALGANCICLOVIR HYDROCHLORIDE
Qualitest PharmaceuticalsValganciclovir